← All insights▼
▼
Sponsor–Industry Alignment· Sponsor ↔ sector
Bill Cassidy (R) is primary sponsor of Pharmaceuticals & Biotech bill s415-117; Pharmaceuticals & Biotech is a top donor industry (8%)
S415-117 would narrow the definition of "active ingredient" in pharmaceutical drug approvals, allowing the FDA to grant extended market exclusivity and priority review status based on a more limited chemical interpretation. Senator Bill Cassidy (R-LA) introduced this bill. Pharmaceuticals & Biotech represents 7.9% of Cassidy's identifiable donor base ($0.67M), ranking #8 among donor industries in his party.
PHR
Pharmaceuticals & Biotech
top donor sector
gave $667K
8% of their funding
▶
Bill Cassidy
R-LA · Senate
sponsored
industry: pharma
▶
BILL
S415-117
their bill
8%
of their classified donations are from this sector
$667K
from Pharmaceuticals & Biotech
#8
most-funded by this sector in their party (of 268)
FOLLOW THE TRAIL
◈ Ask the Analyst about Bill Cassidy →How we built this: a statistical pattern surfaced from public records — FEC campaign finance, Senate/House Lobbying Disclosure Act filings, and Congress.gov. The donor concentration and the legislative action are concurrent facts; this does not imply contributions caused the action, that the member acted improperly, or that the bill specifically benefits the named sector. Generated July 6, 2026 · internal signal score 63/100.